Senate Eying Bill To Block Chinese Biotech Companies, Accused of Aiding CCP’s Military, From Operating in America
Taxpayer dollars should no longer be funding ‘this urgent risk, which grows each day that these companies are permitted to continue aggressively expanding in the U.S. biotech market,’ Senator Hagerty tells the Sun.
Federal agencies could soon be blocked from contracting with Chinese biotech companies accused of granting the Chinese Communist Party access to the medical data of tens of millions of Americans.
The Senate Committee on Homeland Security and Governmental Affairs will hold a hearing on Wednesday on a bill to effectively ban Chinese biotechnology giants from operating in America. The bipartisan legislation would also prohibit Washington from opening contracts with companies that use their equipment or services.
A login link has been sent to
Enter your email to read this article.
Get 2 free articles when you subscribe.
